Dr. Guenther Koehne, MD has an extensive clinical, translational and research program focused on relapsed multiple myeloma, relapsed/refractory myeloma, primary and secondary plasma cell leukemia. He has particular expertise in allogeneic (donor-derived) hematopoietic stem cell transplantation. At Memorial Sloan Kettering Cancer Center, he is pioneering a new type of stem cell transplantation in which we remove a specific subset of cells (T cells) from the donor’s stem cells before the transplant; this significantly reduces the so-called graft-versus-host reactions. As the principle investigator, he is leading several clinical trials to study the effectiveness of T cell-depleted transplants from related and unrelated donors in patients with high-risk multiple myeloma that incorporate myeloma-specific immunotherapies, including donor-derived myeloma-specific T-cell therapies and myeloma vaccine strategies.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811